What what what - results were incredibleWhat happened that I missed. FDA has no choice but to accept. This is enhanced life expectancy for shoot sakes and at minimum non invasive and a combo cure to reduced infringement on the human body systems. Asian deaths explained as NON related. Results again were just amazing. Definitely goin to be a merger coming up as this is the next gotta have drug for the big boy companies. Now PLEASE explain what is so bad with results - anyone - Please... Been loading up all day. Listen to the call, all the questions and re-read results. Nothing to indicate this was a bust phase 2b. Actually amazing for anyone with LN. Win for patients, win for the future to enhance immunotherapy and win for the company to keep investing in research and twigging of the V product for humanity. How can this be bad for shareholders?